• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种基于人工智能的自动化工具用于评估骨髓活检中的网状纤维纤维化

Development of an automated artificial intelligence-based tool for reticulin fibrosis assessment in bone marrow biopsies.

作者信息

D'Abbronzo Giuseppe, D'Antonio Antonio, De Chiara Annarosaria, Panico Luigi, Sparano Lucianna, Diluvio Anna, Sica Antonello, Svanera Gino, De Chiara Giovanni, Fuggi Mariano, Russo Ferdinando, Franco Renato, Ronchi Andrea

机构信息

Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, Università Degli Studi Della Campania "Luigi Vanvitelli", Via Luciano Armanni 5, 80138, Naples, Italy.

Pathology Unit, Hospital "Ospedale del Mare", 80147, Naples, Italy.

出版信息

Virchows Arch. 2025 May 13. doi: 10.1007/s00428-025-04122-5.

DOI:10.1007/s00428-025-04122-5
PMID:40358741
Abstract

Bone marrow fibrosis plays a critical role in the diagnosis, prognosis, and management of haematological disorders, particularly myeloproliferative neoplasms like primary myelofibrosis. Accurate assessment of fibrosis, typically graded through histochemical techniques such as reticulin and trichrome staining, is essential but remains highly dependent on the pathologist's experience. To address the challenges of variability in interpretation and the increasing demand for standardized evaluations, we developed a digital pathology system for automated bone marrow reticulin fibrosis grading. This study utilized 86 bone marrow biopsy specimens from patients diagnosed with Philadelphia chromosome-negative myeloproliferative neoplasms, collected between 2018 and 2023. A fully convolutional network based on the InceptionV3 architecture was trained to assess fibrosis grades (MF0-MF3) from whole slide images of reticulin-stained sections. The model was trained using 3814 annotated images and validated using a separate set of 40 BMBs. The algorithm's performance was evaluated by comparing its fibrosis grading to expert hematopathologists' assessments, yielding a Cohen's kappa coefficient of 0.831, indicating excellent agreement. The algorithm showed strong concordance in fibrosis grading, especially for MF0 (k = 0.918) and MF3 (k = 0.886), and substantial agreement for intermediate grades (MF1 and MF2). Further validation across multiple institutions and scanning platforms confirmed the algorithm's robustness, with an overall agreement of 0.816. These results demonstrate the potential of digital pathology tools to provide standardized, reproducible fibrosis grading, thereby aiding pathologists in clinical decision-making and training.

摘要

骨髓纤维化在血液系统疾病的诊断、预后及管理中起着关键作用,尤其是在原发性骨髓纤维化等骨髓增殖性肿瘤中。纤维化的准确评估通常通过组织化学技术(如网硬蛋白和三色染色)进行分级,这至关重要,但仍高度依赖病理学家的经验。为应对解读变异性的挑战以及对标准化评估日益增长的需求,我们开发了一种用于自动骨髓网硬蛋白纤维化分级的数字病理系统。本研究使用了2018年至2023年期间收集的86例被诊断为费城染色体阴性骨髓增殖性肿瘤患者的骨髓活检标本。基于InceptionV3架构的全卷积网络被训练用于从网硬蛋白染色切片的全切片图像中评估纤维化分级(MF0 - MF3)。该模型使用3814张标注图像进行训练,并使用另一组40张骨髓活检标本进行验证。通过将算法的纤维化分级与血液病理专家的评估进行比较来评估算法的性能,得到的科恩kappa系数为0.831,表明一致性极佳。该算法在纤维化分级方面表现出很强的一致性,尤其是对于MF0(k = 0.918)和MF3(k = 0.886),对于中间分级(MF1和MF2)也有高度一致性。在多个机构和扫描平台上的进一步验证证实了该算法的稳健性,总体一致性为0.816。这些结果表明数字病理工具在提供标准化、可重复的纤维化分级方面的潜力,从而有助于病理学家进行临床决策和培训。

相似文献

1
Development of an automated artificial intelligence-based tool for reticulin fibrosis assessment in bone marrow biopsies.开发一种基于人工智能的自动化工具用于评估骨髓活检中的网状纤维纤维化
Virchows Arch. 2025 May 13. doi: 10.1007/s00428-025-04122-5.
2
Fibrosis identified in the bone marrow biopsies of patients with essential thrombocythemia: its incidence and significance for the differential diagnostic considerations.原发性血小板增多症患者骨髓活检中发现的纤维化:其发生率及在鉴别诊断中的意义
Cesk Patol. 2008 Jul;44(3):62-6.
3
High concordance in grading reticulin fibrosis and cellularity in patients with myeloproliferative neoplasms.骨髓增殖性肿瘤患者网状纤维纤维化和细胞密度分级具有高度一致性。
Mod Pathol. 2014 Nov;27(11):1447-54. doi: 10.1038/modpathol.2014.69. Epub 2014 Apr 25.
4
Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.骨髓增殖性疾病(原发性血小板增多症、真性红细胞增多症、原发性巨核细胞粒细胞化生及骨髓纤维化)的诊断、发病机制与治疗
Neth J Med. 1999 Feb;54(2):46-62. doi: 10.1016/s0300-2977(98)00143-0.
5
Development of an Artificial-Intelligence-Based Tool for Automated Assessment of Cellularity in Bone Marrow Biopsies in Ph-Negative Myeloproliferative Neoplasms.基于人工智能的阴性骨髓增殖性肿瘤骨髓活检细胞密度自动评估工具的开发
Cancers (Basel). 2024 Apr 26;16(9):1687. doi: 10.3390/cancers16091687.
6
Reticulin-Free Quantitation of Bone Marrow Fibrosis in MPNs: Utility and Applications.骨髓增殖性肿瘤中无网硬蛋白定量评估骨髓纤维化:效用及应用
EJHaem. 2025 Feb 27;6(2):e70005. doi: 10.1002/jha2.70005. eCollection 2025 Apr.
7
External validation of an artificial intelligence model for Gleason grading of prostate cancer on prostatectomy specimens.前列腺切除标本中前列腺癌Gleason分级人工智能模型的外部验证
BJU Int. 2025 Jan;135(1):133-139. doi: 10.1111/bju.16464. Epub 2024 Jul 11.
8
Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosis - a consensus-based study.骨髓纤维化、胶原沉积和骨质硬化程度分级中的问题和陷阱——一项基于共识的研究。
Histopathology. 2016 May;68(6):905-15. doi: 10.1111/his.12871. Epub 2015 Nov 20.
9
Diagnostic criteria of the myeloproliferative disorders (MPD): essential thrombocythaemia, polycythaemia vera and chronic megakaryocytic granulocytic metaplasia.骨髓增殖性疾病(MPD)的诊断标准:原发性血小板增多症、真性红细胞增多症和慢性巨核细胞粒细胞化生。
Neth J Med. 1997 Aug;51(2):57-64. doi: 10.1016/s0300-2977(97)00018-1.
10
Prognostic significance of a comprehensive histological evaluation of reticulin fibrosis, collagen deposition and osteosclerosis in primary myelofibrosis patients.原发性骨髓纤维化患者网状纤维纤维化、胶原沉积和骨质硬化的综合组织学评估的预后意义。
Histopathology. 2017 Dec;71(6):897-908. doi: 10.1111/his.13309. Epub 2017 Sep 28.

本文引用的文献

1
Development of an Artificial-Intelligence-Based Tool for Automated Assessment of Cellularity in Bone Marrow Biopsies in Ph-Negative Myeloproliferative Neoplasms.基于人工智能的阴性骨髓增殖性肿瘤骨髓活检细胞密度自动评估工具的开发
Cancers (Basel). 2024 Apr 26;16(9):1687. doi: 10.3390/cancers16091687.
2
Fibrosis and bone marrow: understanding causation and pathobiology.纤维化与骨髓:病因与病理生物学的认识。
J Transl Med. 2023 Oct 9;21(1):703. doi: 10.1186/s12967-023-04393-z.
3
Artificial intelligence in diagnostic pathology.人工智能在诊断病理学中的应用。
Diagn Pathol. 2023 Oct 3;18(1):109. doi: 10.1186/s13000-023-01375-z.
4
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS).骨髓增生异常综合征/肿瘤(MDS)的分类、风险分层和反应评估:国际 MDS 联合会(icMDS)的最新报告。
Blood Rev. 2023 Nov;62:101128. doi: 10.1016/j.blre.2023.101128. Epub 2023 Aug 19.
5
Whole slide imaging (WSI) scanner differences influence optical and computed properties of digitized prostate cancer histology.全切片成像(WSI)扫描仪的差异会影响数字化前列腺癌组织学的光学和计算属性。
J Pathol Inform. 2023 Jul 4;14:100321. doi: 10.1016/j.jpi.2023.100321. eCollection 2023.
6
Shortage of pathologists in Italy: survey of students and residents.意大利病理学家短缺:对学生和住院医师的调查。
Pathologica. 2023 Jun;115(3):172-180. doi: 10.32074/1591-951X-852.
7
Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future.骨髓纤维化与生存预后模型:过去与未来之间的历程
J Clin Med. 2023 Mar 11;12(6):2188. doi: 10.3390/jcm12062188.
8
Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients.纤维化的持续指数化(CIF):改善 MPN 患者的评估和分类。
Leukemia. 2023 Feb;37(2):348-358. doi: 10.1038/s41375-022-01773-0. Epub 2022 Dec 5.
9
Classification and mutation prediction based on histopathology H&E images in liver cancer using deep learning.基于深度学习的肝癌组织病理学苏木精-伊红(H&E)图像分类与突变预测
NPJ Precis Oncol. 2020 Jun 8;4:14. doi: 10.1038/s41698-020-0120-3. eCollection 2020.
10
The differential diagnosis of classical myeloproliferative neoplasms (MPN): the updated WHO criteria.经典型骨髓增殖性肿瘤(MPN)的鉴别诊断:世界卫生组织(WHO)的更新标准
Rinsho Ketsueki. 2019;60(9):1166-1175. doi: 10.11406/rinketsu.60.1166.